Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

Kao Joins Unilever and Geno in Venture to Scale Palm Alternatives

Published September 30, 2022
Published September 30, 2022
Pixabay via Pexel

Kao joins Unilever and Genomatica (Geno), a leader in biotech and sustainability, investing in a venture to scale and commercialize alternatives to palm oil and fossil fuel-derived cleansing ingredients.

WHO: Geno is harnessing biology to remake everyday products and materials built by and for the planet. In response to the urgent climate crisis, Geno is developing and scaling sustainable materials derived from plant- or waste-based feedstocks instead of fossil fuels. Its technology, built over the last 20 years, now drives materials and ingredients in applications ranging from cosmetics and carpets, to home cleaners, apparel, and more. Geno uses the power of biotechnology to convert plant-based raw materials into chemical building blocks that are key components of widely used materials.

Kao creates high-value-added products and services that provide care and enrichment for the life of all people and the planet. Through its portfolio of over 20 leading brands such as Attack, Bioré, Goldwell, Jergens, John Frieda, Kanebo, Laurier, Merries, and Molton Brown, Kao is part of the everyday lives of people in Asia, Oceania, North America, and Europe. Combined with its chemical business, which contributes to a wide range of industries, Kao employs about 33,500 people worldwide and has 135 years of history in innovation.

WHY: Kao's investment adds to Geno's previously announced $120 million venture with Unilever and increases the production capability of the palm kernel oil alternative. It is also a significant step toward achieving Geno's goal to reduce greenhouse gases by 100 million tons in upcoming years. Kao's more than 130 years of expertise in the consumer products and chemical industries deepens the venture's global reach and impact.

The collaboration is a key strategic decision for Kao to accelerate its climate impact and meet its ambitious climate goals, which include reducing its carbon dioxide emissions to zero by 2040 and becoming a carbon-negative company by 2050. As responsibly sourced palm oil and its derivatives will continue to be a critical feedstock to Kao, the venture will support Kao in manufacturing more sustainable, biotechnology-driven ingredients for use in home and personal care products, and supplying palm oil alternatives derivatives to its business customers, and to increase the transparency and traceability of its supply chain.

IN THEIR OWN WORDS: Christophe Schilling, Geno CEO, said, "We're excited to welcome Kao as a founding member to our palm kernel oil alternative venture along with Unilever. Kao joining this venture is another example of Geno collaborating with world-leading brands and value-chain partners to commercialize sustainable solutions at scale that support traceable and responsible sourcing. Together, we will increase the supply chain resiliency our planet and people need today and for the future. Kao's deep expertise in the home and personal care markets enables us to support other manufacturers in meeting their sustainability commitments and supplying the rising consumer demand for sustainable products."

Masahiro Katayose, Kao Senior Executive Officer in charge of Chemical Business, said, "I am delighted that Kao has had the opportunity to invest in a venture with such outstanding, cutting-edge biotechnology capabilities. Besides being a manufacturer of consumer products for household use, Kao is also a chemical manufacturer that supplies the industry with a wide range of materials and has adopted ‘Protecting future lives’ and promoting ‘Sustainability as the only path’ as its mid-term plan K25 vision. To drive sustainable development and contribute toward the building of a resource-circulating society, Kao will continue to undertake responsible, sustainable palm oil procurement. In this regard, Geno's biotechnology has a vital role to play in the diversification of sustainable raw material procurement. Kao's investment in this venture will make possible the provision of new eco-chemical solutions and represents an opportunity for Kao to play an even bigger role in helping consumers, customers, industry and society to realize decarbonization and make the shift to a resource-circulating economy."

DETAILS:

  • Kao makes an investment and joins Geno as a founding member. 
  • In June 2022, Unilever and Geno jointly invested $120 million in the newly formed initiative, with other strategic investors expected to join the venture to develop alternative, plant-based ingredients using biotechnology.
  • Unilever's investment, which is the first to support the venture, also marks the company's largest collaboration in biotechnology alternatives to palm oil to date.
  • Geno will deploy its proven biotechnology platform and is already starting to scale the process for its advanced technology to produce the ingredients. Initial estimates have shown that companies could reduce the carbon footprint of palm-derived ingredients by up to 50% with this technology-driven, plant-based alternative.
×

2 Article(s) Remaining

Subscribe today for full access